Related Experiment Video
Updated: Apr 19, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
A case of etizolam dependence
1Department of Psychiatry, Institute of Human Behaviour and Allied Sciences, Dilshad Garden, New Delhi, India.
Etizolam, a thienodiazepine anxiolytic, may still cause dependence, even if considered lower risk than other benzodiazepines. This case highlights the need for caution when prescribing etizolam for anxiety and depression.
Area of Science:
- Pharmacology
- Psychiatry
Background:
- Etizolam is a thienodiazepine anxiolytic.
- It is often perceived to have a lower dependence potential compared to traditional benzodiazepines.
Observation:
- A case report details a young male experiencing etizolam dependence.
- The patient also presented with social anxiety disorder and moderate depression.
Findings:
- This case demonstrates that etizolam can lead to dependence.
- The potential for dependence should be considered despite its classification.
Implications:
- Prescribers should exercise caution when prescribing etizolam.
- The risk of dependence associated with etizolam is comparable to other benzodiazepines.
Related Concept Videos
CNS Depressants: Barbiturates and Benzodiazepines
Drug Dependence
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

